Interleukin-4 enzyme-linked immunospot assay may be useful for diagnosing sensitization to house dust mite

Background The skin prick test (SPT) is considered a standard test for identification of allergens, but it has some limitations in clinical practice. The multiple allergen simultaneous test (MAST), which measures allergen‐specific immunoglobulin E in patients’ serum, is a widely used alternative tes...

Full description

Saved in:
Bibliographic Details
Published inInternational forum of allergy & rhinology Vol. 6; no. 10; pp. 1007 - 1012
Main Authors Chang, Dong-Yeop, Lee, Jino, Choi, Sung-Won, Lee, Hyeong Joo, Kang, Hyunmo, Yeo, Seong Chul, Joo, Yeon-Hee, Cho, Hyun-Jin, Jeon, Sea-Yuong, Kim, Rock Bum, Kim, Sang-Wook
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.10.2016
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background The skin prick test (SPT) is considered a standard test for identification of allergens, but it has some limitations in clinical practice. The multiple allergen simultaneous test (MAST), which measures allergen‐specific immunoglobulin E in patients’ serum, is a widely used alternative test, but is limited by its relatively low sensitivity and specificity. As a novel diagnostic test to identify allergens, we investigated the sensitivity and specificity of an interleukin‐4 (IL‐4) enzyme‐linked immunospot (ELISpot) assay for Dermatophagoides farinae (Der f) and Dermatophagoides pteronyssinus (Der p). Methods Based on the symptoms and SPT results, 43 house dust mite (HDM) allergic rhinitis (AR) patients and 41 control subjects were included. Peripheral blood was drawn from each subject for IL‐4 ELISpot assay and MAST. The receiver operating characteristic (ROC) curve analysis was conducted to determine the cutoff values. Sensitivity, specificity, and positive and neg predictive values were compared between the 2 tests. Results The sensitivity, specificity, and areas under the ROC curve (AUCs) of the IL‐4 ELISpot assay were 88.4%, 97.6%, and 0.939 for Der f, and 95.3%, 97.5%, and 0.971 for Der p, respectively. However, the sensitivity, specificity, and AUC of MAST were 76.7%, 73.2%, and 0.777 for Der f, and 69.8%, 75.6%, and 0.788 for Der p, respectively. Conclusion The IL‐4 ELISpot assay showed higher sensitivity, specificity, and AUC than MAST, which indicates its clinical feasibility for diagnosing allergy for HDM. A further study is needed to determine the accuracy of the IL‐4 ELISpot assay for other common allergens.
Bibliography:Gyeongsang National University Hospital
ark:/67375/WNG-MRT3Q7GW-G
ArticleID:ALR21786
Ministry of Health and Welfare - No. HI13C13590000
Institute of Health Sciences - No. GNU-2013-02
istex:DF3A46B08B7288C7C8B9A8A56E1295F7055016F6
Korean Health Technology R&D Project
Potential conflict of interest: None provided.
Funding sources for the study: Clinical Research Fund of Gyeongsang National University Hospital (GNUHCRF‐2013‐0001); Institute of Health Sciences (IHS GNU‐2013‐02); Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI13C13590000).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2042-6976
2042-6984
2042-6984
DOI:10.1002/alr.21786